Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.

SIGA Technologies, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

NEW YORK, NOV. 06, 2025 (GLOBE NEWSWIRE) -- SIGA TECHNOLOGIES, INC. (SIGA) (NASDAQ: SIGA), A COMMERCIAL-STAGE PHARMACEUTICAL COMPANY, TODAY REPORTED FINANCIAL RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025. WE CONTINUE TO ADVANCE SIGA'S KEY PRIORITIES WHILE GENERATING $86 MILLION IN PRODUCT REVENUES AND $33 MILLION IN PRE-TAX OPERATING INCOME FOR THE FIRST NINE MONTHS OF 2025," STATED DIEM NGUYEN, CHIEF EXECUTIVE OFFICER.

SIGA REPORTS FINANCIAL RESULTS FOR THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025

NEW YORK, OCT. 30, 2025 (GLOBE NEWSWIRE) -- SIGA TECHNOLOGIES, INC. (SIGA) (NASDAQ: SIGA), A COMMERCIAL-STAGE PHARMACEUTICAL COMPANY, TODAY ANNOUNCED THAT MANAGEMENT WILL HOST A WEBCAST AND CONFERENCE CALL TO PROVIDE A BUSINESS UPDATE AT 4:30 P.M. ET ON THURSDAY, NOVEMBER 6, 2025. PARTICIPATING IN THE CALL WILL BE DIEM NGUYEN, CHIEF EXECUTIVE OFFICER, AND DANIEL LUCKSHIRE, CHIEF FINANCIAL OFFICER.

SIGA TO HOST BUSINESS UPDATE CALL ON NOVEMBER 6, 2025 FOLLOWING RELEASE OF THIRD-QUARTER 2025 RESULTS

ALPHARETTA, GA.--(BUSINESS WIRE)--AGILYSYS, INC. (NASDAQ: AGYS), A LEADING GLOBAL PROVIDER OF HOSPITALITY SOFTWARE AND SERVICES, TODAY ANNOUNCED THAT THE SASKATCHEWAN INDIAN GAMING AUTHORITY (SIGA) HAS CHOSEN AGILYSYS INFOGENESIS POS AND AGILYSYS EATEC INVENTORY AND PROCUREMENT SOLUTIONS FOR ENTERPRISE-WIDE USE ACROSS ALL SEVEN OF ITS CASINO PROPERTIES IN SASKATCHEWAN. THIS MILESTONE REPRESENTS A MAJOR ADVANCEMENT IN SIGA'S STRATEGY TO MODERNIZE ITS OPERATIONS AT SCALE. THIS MODERNIZATION INITI.

SASKATCHEWAN INDIAN GAMING AUTHORITY (SIGA) MODERNIZES POINT-OF-SALE AND INVENTORY OPERATIONS ACROSS SEVEN CASINOS WITH AGILYSYS SOLUTIONS

NEW YORK, AUG. 05, 2025 (GLOBE NEWSWIRE) -- SIGA TECHNOLOGIES, INC. (SIGA) (NASDAQ: SIGA), A COMMERCIAL-STAGE PHARMACEUTICAL COMPANY, TODAY REPORTED FINANCIAL RESULTS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2025.

SIGA REPORTS FINANCIAL RESULTS FOR THREE AND SIX MONTHS ENDED JUNE 30, 2025

NEW YORK, JULY 29, 2025 (GLOBE NEWSWIRE) -- SIGA TECHNOLOGIES, INC. (SIGA) (NASDAQ: SIGA), A COMMERCIAL-STAGE PHARMACEUTICAL COMPANY, TODAY ANNOUNCED THAT MANAGEMENT WILL HOST A WEBCAST AND CONFERENCE CALL TO PROVIDE A BUSINESS UPDATE AT 4:30 P.M. ET ON TUESDAY, AUGUST 5, 2025. PARTICIPATING IN THE CALL WILL BE DIEM NGUYEN, CHIEF EXECUTIVE OFFICER, AND DANIEL LUCKSHIRE, CHIEF FINANCIAL OFFICER.

SIGA TO HOST BUSINESS UPDATE CALL ON AUGUST 5, 2025 FOLLOWING RELEASE OF SECOND-QUARTER 2025 RESULTS

RECEIVED $26 MILLION IV TPOXX PROCUREMENT ORDER FROM THE U.S. GOVERNMENT IN MARCH $94 MILLION IN TPOXX ORDERS (TO BE DELIVERED TO U.S. STRATEGIC NATIONAL STOCKPILE) OUTSTANDING AS OF MARCH 31, 2025 CORPORATE UPDATE CONFERENCE CALL TODAY AT 4:30 PM ET NEW YORK, MAY 08, 2025 (GLOBE NEWSWIRE) -- SIGA TECHNOLOGIES, INC. (SIGA) (NASDAQ: SIGA), A COMMERCIAL-STAGE PHARMACEUTICAL COMPANY, TODAY REPORTED FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2025. SIGA HAS CARRIED ITS MOMENTUM FROM 2024 INTO 2025, ACHIEVING STEADY PROGRESS ON ITS KEY INITIATIVES, STATED DIEM NGUYEN, CHIEF EXECUTIVE OFFICER.

SIGA REPORTS FINANCIAL RESULTS FOR THREE MONTHS ENDED MARCH 31, 2025

NEW YORK, MAY 01, 2025 (GLOBE NEWSWIRE) -- SIGA TECHNOLOGIES, INC. (SIGA) (NASDAQ: SIGA), A COMMERCIAL-STAGE PHARMACEUTICAL COMPANY, TODAY ANNOUNCED THAT MANAGEMENT WILL HOST A WEBCAST AND CONFERENCE CALL TO PROVIDE A BUSINESS UPDATE AT 4:30 P.M. ET ON THURSDAY, MAY 8, 2025. PARTICIPATING IN THE CALL WILL BE DIEM NGUYEN, CHIEF EXECUTIVE OFFICER, AND DANIEL LUCKSHIRE, CHIEF FINANCIAL OFFICER.

SIGA TO HOST BUSINESS UPDATE CALL ON MAY 8, 2025 FOLLOWING RELEASE OF FIRST-QUARTER 2025 RESULTS

NEW YORK, APRIL 08, 2025 (GLOBE NEWSWIRE) -- SIGA TECHNOLOGIES, INC. (SIGA) (NASDAQ: SIGA), A COMMERCIAL-STAGE PHARMACEUTICAL COMPANY, TODAY ANNOUNCED THAT ITS BOARD OF DIRECTORS DECLARED A SPECIAL CASH DIVIDEND OF $0.60 PER SHARE ON THE COMPANY'S COMMON STOCK. THIS REPRESENTS THE FOURTH STRAIGHT YEAR OF A SPECIAL CASH DIVIDEND. THE AMOUNT OF THE DIVIDEND DECLARED IS CONSISTENT WITH THE LEVEL OF THE DIVIDEND DECLARED IN MARCH 2024. THE DIVIDEND IS PAYABLE ON MAY 15, 2025, TO SHAREHOLDERS OF RECORD AT THE CLOSE OF BUSINESS ON APRIL 29, 2025.

SIGA DECLARES SPECIAL CASH DIVIDEND OF $0.60 PER SHARE

NEW YORK, MARCH 18, 2025 (GLOBE NEWSWIRE) -- SIGA TECHNOLOGIES, INC. (SIGA) (NASDAQ: SIGA), A COMMERCIAL-STAGE PHARMACEUTICAL COMPANY, ANNOUNCED TODAY THE APPOINTMENT OF RETIRED UNITED STATES ARMY GENERAL JOHN JACK KEANE TO ITS BOARD OF DIRECTORS, EFFECTIVE IMMEDIATELY. GENERAL KEANE, A RETIRED FOUR-STAR GENERAL, COMPLETED 37 YEARS OF PUBLIC SERVICE IN DECEMBER 2003, CULMINATING WITH HIS APPOINTMENT AS ACTING CHIEF OF STAFF AND VICE CHIEF OF STAFF OF THE U.S. ARMY FROM 1999 TO 2003.

SIGA APPOINTS RETIRED GENERAL JOHN M. KEANE TO ITS BOARD OF DIRECTORS

NEW YORK, MARCH 11, 2025 (GLOBE NEWSWIRE) -- SIGA TECHNOLOGIES, INC. (SIGA) (NASDAQ: SIGA), A COMMERCIAL-STAGE PHARMACEUTICAL COMPANY, TODAY REPORTED FINANCIAL RESULTS FOR THE THREE AND TWELVE MONTHS ENDED DECEMBER 31, 2024.

SIGA Technologies, Inc.

SIGA

Price

Financial Reports

No items found.

Press Releases

SIGA Technologies, Inc.

SIGA.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

SIGA